摘要:
A system that includes a talker, a listener, and a controller may communicate over an Ethernet Audio/Video Bridging network. The controller may communicate control messages to manage data streams between the talker and the listener through one or more application layer interfaces of the talker and the listener. Based on the control messages, the talker and the listener may communicate using a Stream Reservation Protocol to reserve connection for, or remove connection from, the data streams. The talker and listener may communicate the success of reserving or removing the connections to the controller through the application layer interfaces.
摘要:
An ink container has a first chamber configured to contain ink, a second chamber configured to enclose an ink-air separating membrane consisting of a wet side portion and a dry side portion, and a structure configured to connect the first and second chambers. A sealing arrangement which is associated with the structure and which keeps the first and second chambers fluidly isolated from each other until the ink container is disposed on a printer ink supply station and ink can be supplied from the first chamber to the printer.
摘要:
An ink supply for a push-primed inkjet printer including an ink reservoir, a housing, and a pair of valves. The housing may enclose the ink reservoir and define an opening that provides fluid communication between the ink reservoir and outside the housing. The pair of valves may be coupled to the housing, arranged in series, and configured to control the fluid communication.
摘要:
Compounds of Formula I, stereoisomers, and pharmaceutically acceptable salts or prodrugs thereof, their preparation, and their uses for the treatment of hepatitis C viral infection are described:
摘要:
An apparatus for use in a fluid delivery system includes a housing configurable to separate a first volume of gas from a second volume of gas and an interface arranged within the housing. The interface includes a bubbler member that is fluidically wetted with a fluid via capillary action. The interface is configured to allow a gas from the first volume of gas to pass through the fluid into the second volume of gas when a pressure difference between the first and second volumes of gas reaches a first threshold level. The interface is also configured to allow a gas from the second volume of gas to pass through the fluid into the first volume of gas when the pressure difference between the first and second volumes of gas reaches a second threshold level.
摘要:
Thee present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA via replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or creating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.
摘要:
An ink container has a first chamber configured to contain ink, a second chamber configured to enclose an ink-air separating membrane consisting of a wet side portion and a dry side portion, and a structure configured to connect the first and second chambers. A sealing arrangement which is associated with the structure and which keeps the first and second chambers fluidly isolated from each other until the ink container is disposed on a printer ink supply station and ink can be supplied from the first chamber to the printer.
摘要:
The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.